Skip to content
10-Q

Quarterly Report

Raptor Pharmaceutical Corp

0001564590-16-022756

← back to feed
Filed
Aug 4, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 2, 2016 85.31M sh
Capex Q2 2016 · Jun 30, 2016 $581K
Capex Q2 2016 · Jun 30, 2015 $2.32M
Long Term Debt Q2 2016 · Jun 30, 2016 $45M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $124.24M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $157.35M
Cash And Equivalents Q2 2016 · Jun 30, 2015 $192.99M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $149.61M
Stockholders Equity Q2 2016 · Jun 30, 2016 $67.69M
Stockholders Equity Q2 2016 · Dec 31, 2015 $117.19M
Current Liabilities Q2 2016 · Jun 30, 2016 $43.92M
Current Liabilities Q2 2016 · Dec 31, 2015 $39.46M
Total Liabilities Q2 2016 · Jun 30, 2016 $287.25M
Total Liabilities Q2 2016 · Dec 31, 2015 $302.3M
Current Assets Q2 2016 · Jun 30, 2016 $156.79M
Current Assets Q2 2016 · Dec 31, 2015 $181.4M
Total Assets Q2 2016 · Jun 30, 2016 $354.94M
Total Assets Q2 2016 · Dec 31, 2015 $419.49M
Rd Expense Q2 2016 · Jun 30, 2016 $15.69M
Rd Expense Q2 2016 · Jun 30, 2016 $29.7M
Rd Expense Q2 2016 · Jun 30, 2015 $11.88M
Rd Expense Q2 2016 · Jun 30, 2015 $28.43M
Net Income Q2 2016 · Jun 30, 2016 −$14.02M
Net Income Q2 2016 · Jun 30, 2016 −$55.6M
Net Income Q2 2016 · Jun 30, 2015 −$13.95M
Net Income Q2 2016 · Jun 30, 2015 −$33.63M
Operating Income Q2 2016 · Jun 30, 2016 −$9.45M
Operating Income Q2 2016 · Jun 30, 2016 −$45.59M
Operating Income Q2 2016 · Jun 30, 2015 −$8.96M
Operating Income Q2 2016 · Jun 30, 2015 −$23.61M
Gross Profit Q2 2016 · Jun 30, 2016 $27.1M
Gross Profit Q2 2016 · Jun 30, 2016 $50.24M
Gross Profit Q2 2016 · Jun 30, 2015 $20.69M
Gross Profit Q2 2016 · Jun 30, 2015 $37.42M